Clinical articles on drug interactions and medication safety — sourced from 257,000+ FDA drug labels.
Clarithromycin is contraindicated with simvastatin due to dangerous CYP3A inhibition. Learn why from FDA data and what alternatives exist.
Explore the rosuvastatin-gemfibrozil interaction with FDA data. Learn safety concerns, monitoring needs, and risk factors from FDA drug l...
FDA data on rosuvastatin and azithromycin safety. Why pharmacists flag this combination and what you need to know.
Clinical analysis of simvastatin-amiodarone interaction, CYP3A4 metabolism, myopathy risk, and dose management. Evidence-based guidance.
Is it safe to take atorvastatin with warfarin? Learn the interaction risk, what FDA data shows, and what your pharmacist needs to know.
Learn if fenofibrate and gemfibrozil can be taken together. Review FDA labeling, risks, and what to watch for with your doctor.
FDA data on lovastatin and ezetimibe together. Muscle risk, LDL reduction rates, and pharmacokinetic interactions explained.
Learn about combining rosuvastatin and pravastatin. FDA labeling, safety data, and what patients should know about dual statin therapy.
Learn why combining atorvastatin and simvastatin is contraindicated. FDA labeling data on statin interactions and safer alternatives.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and NIH NLM. For informational purposes only.